Dr. Kettel

Dr. L. Michael Kettel - Extended Curriculum Vitae

Personal Information

Name: L. Michael Kettel

Office Address:
San Diego Fertility Center
11425 El Camino Real
San Diego, CA 92130

Office Telephone: (858) 794-6363

Office FAX: (858) 794-6360

Date of Birth: 2/27/56

Place of Birth: Chicago, Illinois

Citizenship: USA

Spouse: Faith Reichert Kettel

Children:
Jennifer Ann Kettel, born 8/4/85
James Michael Kettel, born 6/2/88
Jonathan Michael Kettel, born 6/2/88

Education

Undergraduate: University of Arizona; Tucson, Arizona

Degree: Bachelor of Science in Pharmacy
Honors:
1) Dean's List for Scholastic Honors
2) Rho Chi Society (pharmacy honorary)
Organizations: Sigma Phi Epsilon fraternity

Medical Education: University of Arizona; Tucson, Arizona

Degree: Doctor of Medicine
Honors:
1) Alpha Omega Alpha (AOA), elected 1982
2) Upjohn Achievement Award, 1983
Scholastic Activities: President, Alpha Omega Alpha, 1982-1983

Residency: University of Utah; Salt Lake City, Utah

Specialty: Obstetrics and Gynecology
Honors:
1) Department of Obstetrics and Gynecology Resident Teaching Award, 1985
2) Department of Obstetrics and Gynecology Resident Teaching Award, 1986
3) University of Utah Outstanding Houseofficer Award (Class of 1986)

Fellowship: University of California-San Diego, La Jolla, California

Specialty: Reproductive Endocrinology and Infertility
Director: Samuel S.C. Yen, M.D., D.Sc.

Licensure & Boards

Medical Licensure:
Utah 84-171882-1205
California G059705

Pharmacy Licensure: Arizona 6741

Diplomat, National Board of Medical Examiners: ID #285952

Fellow, American College of Obstetrics and Gynecology; 1990

Board Certified: Obstetrics and Gynecology, 1990; re-certified 1999

Subspecialty Board Certified: Reproductive Endocrinology and Infertility, 1991, re-certified 1999

High Complexity Laboratory Director (HCLD), American Board of Bioanalysis. 2000

Embryology Laboratory Director (ELD), American Board of Bioanalysis. 2005

Academic Appointments

1987-1988 Clinical Instructor, Department of Reproductive Medicine, University of California, San Diego

1989-1995 Assistant Clinical Professor, Department of Reproductive Medicine, University of California, San Diego

1995-2003 Associate Clinical Professor, Department of Reproductive Medicine, University of California, San Diego

2003-present Clinical Professor, Department of Reproductive Medicine, University of California, San Diego

Society Memberships

  • Alpha Omega Alpha
  • American Medical Association
  • California Medical Association
  • American College of Obstetrics and Gynecology
  • American Society of Reproductive Medicine
  • Society of Reproductive Surgeons
  • Society of Reproductive Endocrinologists
  • Society of Assisted Reproductive Technology
  • The Endocrine Society
  • Pacific Coast Reproductive Society
  • Pacific Coast Obstetrical and Gynecological Society
  • San Diego Reproductive Endocrine Society
  • San Diego Gynecological Society
  • San Diego County Medical Society
  • Southwest Obstetrical and Gynecological Society

Listed

  • American Board of Medical Specialties
  • Who’s Who in America
  • "Best Doctors in America" (1996-2014)
  • Top Obstetricians and Gynecologists; Consumers’ Research Council of America, 2002-present.
  • Best Doctors in San Diego, San Diego Magazine, 2002-2005.
  • Top Physicians; Consumers’ Research Council of America, 2003-2007

Teaching Assignments

Lecturer; Endocrinology, Reproduction, and Metabolism (SOM 209), University of California-San Diego, School of Medicine; 1988 - present.

Course Coordinator; Endocrine Rounds, University of California-San Diego, Department of Reproductive Medicine; 1989 - 1996.

Course Coordinator; Endocrinology, Reproduction and Metabolism (SOM 209); University of California-San Diego, School of Medicine; 1991 - 2001.

Lecturer; Perinatal Epidemiology (SOM 232), University of California-San Diego, School of Medicine, Assisted Reproductive Technologies; 1995-present.

Administrative Service

University of Utah, Department of Obstetrics and Gynecology; Promotion, Tenure, and Review Committee 1985-1987.

University of Utah, School of Medicine; Promotion, Tenure, and Review committee 1987.

University of California-San Diego, School of Medicine; Pharmacy and Therapeutics Committee, 1989 - 1996.

University of California-San Diego, School of Medicine; Interdisciplinary Practices Committee Meeting, 1989.

University of California-San Diego, School of Medicine; Laser Practice Committee, 1992 - 1996.

University of California-San Diego, Medical Center; Thornton Hospital Operating Room Advisory Committee 1993 - 1996.

San Diego Reproductive Endocrine Society; Program Chairman 1992 - 1993.

San Diego Reproductive Endocrine Society; President 1993 - 1994, 2005 - 2007.

San Diego County Medical Society; Editorial Board, The San Diego Physician, 1996 - 2000

San Diego County Medical Society; Credentials Committee, 1996 - 2000.

San Diego County Medical Society; Nominating Committee, 2000-2003

Scripps Memorial Hospital, Pharmacy & Therapeutics Committee, 1996 - 1998.

Society of Assisted Reproductive Technology; Validation Committee, 1998-present.

Pacific Coast Reproductive Society; Board of Directors 1999-2007

Pacific Coast Reproductive Society; Grants Committee 1999

Pacific Coast Reproductive Society; Program Chairman 1999/2000

Pacific Coast Reproductive Society; Abstract Committee 2000, 2001, 2004, 2005, 2006

Pacific Coast Reproductive Society; Awards Committee 2000, 2001, 2002

Pacific Coast Reproductive Society; Membership Committee Chair 2003

Society of Reproductive Endocrinology and Infertility; Nominating Committee, 2000-2002

Society for Reproductive Endocrinology and Infertility, Board of Directors, 2002-2004

San Diego Reproductive Endocrine Society, Secretary/Treasurer 2002-2003

Society of Assisted Reproductive Technology; Quality Assurance Committee, 2002-present

Society of Reproductive Surgeons, Abstract Review Committee, 2003

Pacific Coast Reproductive Society, President-Elect, 2004

Society of Assisted Reproductive Technology, Abstract Review Committee, 2004-2008

Pacific Coast Reproductive Society, President, 2005

Pacific Coast Reproductive Society, Advisor to the Board, 2008

Pacific Coast Obstetrical and Gynecological Society, Arrangements Chair 2008-2009

Academic Service

Post-graduate Education

Faculty - Basic Obstetrical and Transvaginal Ultrasound Course, October 1991. University of California-San Diego, School of Medicine.

Faculty - Advanced Laparoscopy and Hysteroscopy in Gynecology, Hotel del Coronado, June 1992.

Faculty - National Institute of Health, National Institute of Child Health and Human Development Workshop on Abnormal Bleeding, Leiomyomas and Infertility, Washington, D.C. June 1992.

Faculty - Scientific Review Program. RFA HD 92-06, Contraceptive Development Research Centers, National Institute of Health, National Institute of Child Health and Human Development, Washington, D.C. July 22-24, 1992.

Faculty - Primary Care Medicine: A Practical Approach. Clinical Approach to Aging in Women. Coronado, CA. August 21-23, 1992.

Faculty - Advanced Laparoscopy and Hysteroscopy. Loew's Coronado Resort, March 10-13, 1993.

Faculty - Advanced Laparoscopy and Pelviscopy: a Practical Approach. Hyatt Islandia, May 21-23, 1993.

Faculty - Primary Care Medicine: A Practical Approach. Update on Hormonal Contraceptives. Coronado, CA. August 21-22, 1993.

Faculty - Frontiers in Ovulation Induction. Marina del Rey, CA. September 22 - 23, 1993.

Faculty - 43rd Annual Meeting Southwest Obstetrical and Gynecological Society, San Diego, CA. October 17-21, 1993.

Faculty - Controversies in Reproductive Endocrinology: A Practical Approach. Marco Island, FL. February 3-5, 1994.

Faculty - 1994 Update in Obstetrics and Gynecology. Brigham and Women's Hospital. Harvard Medical School, Boston, MA. March 17, 1994.

Faculty - 1994 Update in Obstetrics and Gynecology, 20th Annual San Diego Gynecological Society Symposium. La Jolla, CA, March 19, 1994.

Faculty - Alternatives to Hysterectomy -- Bench to Bedside Meeting. National Institutes of Health, National Institute of Child Health and Human Development, Bethesda, MD May 23-24, 1994.

Faculty - Endometriosis Study Group. Beaver Creek, CO, August 19-21, 1994.

Faculty - Frontiers in Ovulation Induction. San Francisco, CA. September 29-30, 1994.

Faculty - Mid-winter Update in Obstetrics and Gynecology, Phoenix Obstetrical and Gynecological Society and Maricopa County Hospital Department of Obstetrics and Gynecology. Scottsdale, AZ. February 16-18, 1995.

Faculty - Clinical Applications of Anti-progestins. The American Society of Reproductive Medicine, Roundtable, Seattle, WA, October 18, 1995.

Faculty - The Endocrine Society Clinical Endocrinology Update: 1995, La Jolla CA, October 24, 1995

Faculty - Complications in Laparoscopic Surgery. The American Association of Gynecologic Laparoscopists. Orlando, FL, November 9, 1995

Faculty - Laparoscopic Myomectomy. The American Association of Gynecologic Laparoscopists. Orlando, FL, November 9, 1995.

Faculty - Practical Evaluation of the Infertile Patient. Topics and Advances in Internal Medicine: 1996. San Diego, CA. February 21-22, 1996.

Faculty - Clinical Applications of Anti-progestins. The Pacific Coast Fertility Society, Roundtable. Indian Wells, CA, April 20, 1996.

Faculty - Cost Effective Use of Ultrasound in the Gynecologic Patient. Gynecology Update: Technique and Controversy. La Jolla, CA, June 7-8, 1996.

Faculty - Special Problems of the Female Athlete. Sports and Occupational Medicine Update. San Diego, CA, June 10, 1996.

Faculty - Reproductive Concerns with Muellerian Anomalies. First Friday Perinatal Conference. San Diego, CA, August 2, 1996

Faculty - Clinical Applications of Anti-progestins. The American Society of Reproductive Medicine, Roundtable, Boston, MA, November 5, 1996.

Faculty - Clinical Applications of Anti-progestins. The American Society of Reproductive Medicine, Roundtable, Cincinnati, OH, November 5, 1997.

Faculty - Controversies in Gynecology. The Pacific Coast Fertility Society. Indian Wells, CA, April 23, 1998.

Faculty - Clinical Applications of Anti-progestins. The American Society of Reproductive Medicine, Roundtable, San Francisco, CA, October 5, 1998.

Faculty - Recent Advances in Assisted Reproductive Technology. The California Society of Hospital Pharmacists. San Diego, CA, March 20, 1999.

Faculty - GnRH Antagonists. The Pacific Coast Reproductive Society, Roundtable, La Costa, CA, April 18, 1999.

Faculty - Primary Care Essentials, Abnormal uterine bleeding & Practical evaluation of amenorrhea. CMEA, San Francisco, CA, May 17, 1999.

Program Chair – Pacific Coast Reproductive Society Annual Meeting 2000: Reproductive Medicine 2000. Rancho Mirage, CA, April 2000.

Faculty – Issues in Women’s Health, Abnormal uterine bleeding & Practical evaluation of amenorrhea. MER, Las Vegas, NV, June 2000.

Faculty – Ovulation Induction for In-Vitro Fertilization. The Pacific Coast Reproductive Society, Roundtable, Rancho Mirage, CA, April 27, 2001.

Faculty – 2001 Northern Perinatal Outreach Conference, Planning an effective infertility treatment strategy & New Horizons in ART. Jackson Hole, WY, September 12, 2001

Faculty – Managing Unexplained Infertility in a World without ART. Pacific Coast Reproductive Society Annual Meeting 2002: Postgraduate course, Rancho Mirage, CA. April 2002

Faculty – Society of Reproductive Endocrinology and Infertility and American Society of Reproductive Medicine Fellows Retreat, Aspen, CO. August 2002

Faculty – American Infertility Association and Serono Symposia International. Insights into Infertility, Manhattan Beach, CA October 2003

Faculty – IVF in the 21st Century. The California Association of Neonatologists Annual Meeting, Coronado, CA. February 2004

Faculty – Endometrial Preparation in Third Party Reproduction Cycles. The Pacific Coast Reproductive Society, Roundtable, Indian Wells, CA, April 28, 2006.

Faculty – A Twenty-first century approach to the couple with unexplained infertility. American Society of Reproductive Medicine Annual Meeting, Roundtable, New Orleans, LA, October 23, 2006.

Faculty – Preimplantation Genetic Diagnosis. The Pacific Coast Reproductive Society, Roundtable, Rancho Mirage, CA, April 19, 2007.

Peer Review

  • Ad Hoc Reviewer Fertility & Sterility, 1991 - present.
  • Ad Hoc Reviewer Human Reproduction, 1994 - present.
  • Ad Hoc Reviewer American Journal of Obstetrics and Gynecology, 1994 - present.
  • Ad Hoc Reviewer Obstetrics & Gynecology, 1997-present

Grants & Awards

Andrew W. Mellon Foundation
Faculty Scholar Award
Project Period: 7/01/89 - 6/30/90
Award: $ 71,138

Co-investigator UCSD Number: 89-6621
Title: RU-486 in the treatment of endometriosis
Agency: Institute Roussel, UCLAF
Project Period: 8/01/89 - 1/31/91
Award: $135,487

Co-investigator UCSD Number: 90-5171
Title: Hypothalamic Amenorrhea: Neuroendocrine characterization
Agency: NIH Agency Number - 5 RO1 HD21198-05
Project Period: 12/01/85 - 5/31/93
Award: $176,153

Co-investigator UCSD Number: 91-5119
Title: Control of the Hypothalamic-Hypophyseal-Ovarian System
Agency: NIH Agency Number - 5 P50 HD12303-13
Project Period: 12/01/78 - 11/30/92
Award: $631,674

Co-investigator UCSD Number: 92-6556
Title: Neuroendocrine-Metabolic Control of the Menstrual Cycle
Agency: NIH Agency Number - 2 P50 HD 12303-15
Project Period: 4/01/93 - 3/31/98
Award: $1,013,432
Annual Direct Costs: $632,877

Co-investigator UCSD Number: 93-6686
Title: Chronic anovulation: mechanisms and consequences.
Agency: NIH Agency Number - 2 P50 HD12303-15Sl
Project Period: 6/1/93 - 5/31/95
Annual Direct Costs: $90,424

Co-investigator UCSD Number: 93-6841
Title: Development of long-term treatment strategies for uterine leiomyoma using RU486.
Project Period: 6/1/93 - 5/31/94
Annual Direct Costs: $90,424

Principal Investigator UCSD Number: 93-762
Title: Myomectomy incision adhesion prophylaxis using the Gore-Tex surgical membrane.
Agency: W.L. Gore and Associates, Inc.
Project Period: 10/1/91 - 10/95
Annual Direct Costs: $12,000

Co-investigator UCSD Number: 92-159
Title: A multicenter trial comparing Zoladex therapy with and without hormone replacement for the treatment of endometriosis.
Agency: ICI Pharmaceuticals
Project Period: 3/92 - 3/94
Annual Direct Costs: $20,000

Principal Investigator UCSD Number: 92-813
Title: Double-blind study of two doses of Lupron Depot vs. placebo in the treatment of hypermenorrhea-induced anemia in patients with leiomyomata uteri.
Agency: TAP Pharmaceutical Products, Inc.
Project Period: 6/91 - 6/94
Annual Direct Costs: $20,667

Principal Investigator UCSD Number 94-449
Title: Evaluation of the safety and effectiveness of HAL-F membrane in reducing post-operative adhesion formation to serosal tissue.
Agency: Genzyme Corporation
Project Period: 6/94-7/96
Annual Direct Costs: $21,000

Principal Investigator PTL-0013
Title: Clinical Evaluation of Lubricoat 0.5% Ferric Hyaluronate Gel for the Reduction of Adhesions Following Peritoneal Cavity Surgery, A Multicenter Study of Safety and Efficacy.
Agency: Lifecore Biomedical
Project Period: 9/96-3/99
Annual Direct Costs: $54,000

Principal Investigator PTL-0070
Title: Clinical Evaluation of Laparoscopic Placement of Lubricoat 0.5% Ferric Hyaluronate Gel for the Reduction of Adhesions Following Peritoneal Cavity Surgery
Agency: Lifecore Biomedical
Project Period: 9/97-9/99
Annual Direct Costs: $150,000

Principal Investigator Classic ML/IC087
Title: A comparative, open-label, randomized, multicenter pilot study to determine the safety and efficacy of Icodextrin in the reduction of post-surgical adhesions after laparoscopic surgery.
Agency: ML Laboratories
Project Period: 9/98-2/00
Annual Direct Costs: $155,000

Principal Investigator 058-004
Title: An open-label, randomized, group comparative, multicenter study to assess the efficacy and safety of a Follistim solution formulation compared to a freeze-dried cake formulation, both administered subcutaneously for the induction of ovulation in clomiphene-resistent subjects with chronic anovulation (WHO Group II)
Agency: Organon Pharmaceutical, Division of Akzo-Nobel
Project Period: 9/98-8/99
Annual Direct Costs: $55,000

Principal Investigator FLGL-001-USA
Title: A randomized, controlled, single-blind trial to evaluate the safety, plasma time course, and efficacy of AF0157 (poloxamer 407 and carboxymethylcellulose sodium) for the reduction of post-surgical ovarian adhesions
Agency: Alliance Pharmaceuticals
Project Period: 3/99-11/99
Annual Direct Costs: $65,000

Principal Investigator RLIF.C.001
Title: a phase I/II placebo-controlled study of the safety and efficacy of recombinant human relaxin in subjects undergoing an egg donation cycle
Agency: Connetics Corporation
Project Period: 3/00-6/01
Annual Direct Costs: $110,000

Principal Investigator RLIF.C.002
Title: A phase I/II placebo-controlled study of the safety and efficacy of recombinant human relaxin in infertile subjects undergoing clomiphene citrate therapy.
Agency: Connectics Corporation
Project Period: Canceled
Annual Direct Costs: $110,000

Principal Investigator ORG 058-005
Title: An open, cross-over, three-center, pilot study to compare single subcutaneous administration of Follistim and oral clomiphene citrate as treatment for anovulation in chronic anovulatory infertility women.
Agency: Organon Pharmaceutical, Division of Akzo-Nobel
Project Period: 3/00-11/00
Annual Direct Costs: $55,000

Principal Investigator FPI Purified Repronex 2000-02
Title: A randomized, open-label, parallel group, multi-center efficacy study comparing Purifed Repronex IM and Repronex SC in female patients undergoing In-Vitro Fertilization (IVF)
Agency: Ferring Pharmaceuticals, Inc.
Project Period: 11/00-3/01
Annual Direct Costs: $92,000

Principal Investigator INS1-PO-15
Title: A randomized, placebo controlled, double-blind, parallel group clinical study to assess the effect of D-chiro-Inositol (INS-1) on clomiphene citrate induced ovulation in women with polycystic ovary syndrome (PCOS).
Agency: Insmed Incorporated
Project Period: 12/00-3/02
Annual Direct Costs: $48,000

Principal Investigator Serono Study 22381
Title: A phase III, prospective, randomized, multi-center, multi-national, double-blind, double-dummy, parallel group study to compare the safety and efficacy of a new formulation of recombinant human FSH (r-hFSH) versus Fertinex in stimulating multiple follicular development prior to ART in patients pretreated with GnRH-agonist.
Agency: Serono Pharmaceuticals
Project period: Canceled
Annual Direct Costs: $96,000

Principal Investigator FPI Purified Repronex 2000-01
Title: A randomized, open-label, parallel group, multi-center efficacy study in anovulatory or oligo-ovulatory infertile female patients comparing Purifed Repronex SC, Purified Repronex IM and Repronex SC for ovulation induction.
Agency: Ferring Pharmaceutical Inc.
Project Period: 03/01-1/02
Annual Direct Costs: $52,000

Principal Investigator Organon 142-002
Title: An open-label, non-controlled multi-center study to evaluate subject comprehension, ease of use, safety and efficacy of the Follistim Pen for the self-administration of Follistim-AQ cartridge for induction of ovulation in clomiphene-resistant women with chronic anovulation (WHO Group II)
Agency: Organon Pharmaceutical, Division of Akzo-Nobel
Project period: 1/02-10/02
Annual Direct Costs: $110,000

Principal Investigator ML/AD 002 PAMELA Study
Title: A pivotal, double-blind, comparative, multicentre study to determine the efficacy and safety of Adept in the reduction of post-surgical adhesions after laparoscopic surgery.
Agency: ML Laboratories, PLC
Project Period: 5/01-4/04
Annual Direct Costs: $94,000

Principal Investigator Organon/Genesis PGD Study
Title: Pre-implantation genetic diagnosis (PGD) as both a diagnostic and therapeutic tool in assisted reproductive technology (ART), a randomized, controlled, multi-center trial
Agency: Educational grant from Organon Pharmaceutical, Division of Akzo-Nobel
Project period: 6/01-present
Annual Direct Costs: $140,000

Principal Investigator TAP M01-394
Title: A Phase III, 12-month, randomized, double-blind study to evaluate the efficacy and safety of two doses of J867 versus placebo in subjects with uterine leiomyomata
Agency: TAP Pharmaceutical Products, Inc.
Project Period: 9/01-7/04
Annual Direct Costs: $74,000

Principal Investigator Chito-03
Title: A safety and efficacy study of N,O-carboxymethylchitosan (NOCC) when used for reduction of postoperative adhesion development in women undergoing laparoscopy.
Agency: Chitogenics, Inc.
Project Period: 11/02-7/04
Annual Direct Costs: $89,000

Co-Investigator Serono Study 24688
Title: A phase IV, multicenter, open-lable, randomized study to compare the safety and efficacy of Cetrotide 3 mg versus Antagon in the inhibition of a premature LH surge in a r-hFSH/hMG stimulation cycle with OCP programming in women undergoing ovarian stimulation prior to ART.
Agency: Serono, Inc.
Project Period: 10/03–7/04
Annual Direct Costs: $98,000

Principal investigator TAP MO1-391
Title: A phase 3, 12-month extension study to evaluate the safety of asoprisnil (J867) in subjects with uterine leiomyomata.
Agency: TAP Pharmaceutical Products, Inc.
Project Period: 3/04-present
Annual Direct Costs: $74,000

Principal Investigator IBSA 03CHUS/FSH03
Title: A prospective, multicenter, investigator blinded randomized concurrent control study of the clinical efficacy and tolerability of two highly purified FSH preparations (Fostimon versus Bravelle) in women undergoing controlled ovarian stimulation for In-Vitro Fertilization (IVF).
Agency: IBSA Institut Biochemique SA
Project Period: 3/05-present
Annual Direct Costs: $200,000

Principal Investigator, FZ-GYN003
Title: Pivotal Clinical Trial to Determine the Safety and Efficacy of Oxiplex/AP Gel for the Reduction of Postoperative Adhesions Following Laparoscopic Gynecological Surgery
Agency: FzioMed, Inc.
Project Period: 06/05 – Present (suspended)
Annual Direct Costs: $45,000

Principal Investigator, TAP A-FB04-078
Title: A Phase III, Continuation Study to Evaluate the Long-Term Safety of
Asoprisnil in Subjects with Uterine Leiomyomata
Agency: TAP Pharmaceuticals Products, Inc
Project period: 06/05- 6/06
Annual Direct Costs: $40,000

Co-Investigator, Ferring Pharmaceuticals 2004-02
Title: A Multi-Center, Randomized, Open-Label, Parallel Group Study of a Vaginal Micronized 56tProgesterone Tablet (Endometrin) Compare to Crinone 8% Vaginal Gel in Female Patients Undergoing In-Vitro Fertilization (IVF)
Agency: Ferring Pharmaceuticals
Project Period: 6/05 – 9/06
Annual Direct Costs: $85,000

Principal Investigator, Duramed Research DR-MPG-201
Title: A Phase II, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Induction of Withdrawal Bleeding After Administration of Oral Micronized Progesterone in Women with Secondary Amenorrhea
Agency: Duramed Pharmaceuticals
Project Period: 10/05-5/07
Annual Direct Costs: $30,000

Bibliography

A. Peer Reviewed Papers:

  1. Kettel LM, Branch DW, Scott JR. Occult placental abruption after maternal trauma. Obstet Gynecol 1988; 71:449-53.
  2. Kettel LM, Hebertson RM. Sacrospinous ligament suspension of the prolapsed vaginal vault and the surgical dissection of the sacrospinous ligament. Surg Gynecol Obstet 1989; 168:318-22.
  3. Roseff SJ, Bangah ML, Kettel LM, Vale W, Rivier J, Burger HG, Yen SSC. Dynamic changes in circulating inhibin levels during the luteal-follicular transition of the human menstrual cycle. J Clin Endocrinol Metab 1989; 69:1033-9.
  4. Kettel LM, Murphy AA. Combination medical and surgical therapy for infertile patients with endometriosis. Obstet Gynecol Clinics 1989; 16:167-77.
  5. Roseff SJ, Kettel LM, Ulmann A, Bangah ML, Rivier J, Burger HG, Baulieu E, Vale W, Yen SSC. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of GnRH and progesterone to late luteal phase women. Fertil Steril 1990; 54:805-10.
  6. Kettel LM. Estrogen hormone replacement to minimize cardiovascular risk. West J Med 1990; 152:408-9.
  7. Berga SL, Loucks AB, Rossmanith WG, Kettel LM, Laughlin GA, Yen SSC. Acceleration of LH pulse frequency in functional hypothalamic amenorrhea by dopaminergic blockade. J Clin Endocrinol Metab 1991; 72:151-56.
  8. Kettel LM, Roseff SJ, Bangah ML, Burger HG, Yen SSC. Circulating levels of inhibin in pregnant women at term: Simultaneous disappearance with estradiol and progesterone after delivery. Clin Endocrinol (Oxf) 1991; 34:19-23.
  9. Kettel LM, Roseff SJ, Chiu TC, Bangah ML, Vale W, Rivier J, Burger HG, Yen SSC. Follicular arrest during the mid-follicular phase of the menstrual cycle: a gonadotropin-releasing hormone antagonist imposed follicular-follicular transition. J Clin Endocrinol Metab 1991; 73:644-49.
  10. Kettel LM, Murphy AA, Mortola JF, Liu JH, Ulmann A, Dubois C, Baulieu EE, Yen SSC. Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis. Fertil Steril 1991; 56:402-7.
  11. Kettel, LM. Management of hirsutism. West J Med 1992;156:648.
  12. Murphy AA, Nager CW, Wujek JJ, Kettel LM, Torp VA, Hanson RE, Chin HG. Operative laparoscopy vs. laparotomy for the management of ectopic pregnancy: a prospective randomized trial. Fertil Steril 1992;57:1180-1185.
  13. Greene KE, Kettel LM, Yen SSC. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: A contraceptive potential. Fertil Steril 1992; 58:338-43.
  14. Murphy AA, Kettel LM, Morales AJ, Roberts VG, Yen SSC. Regression of uterine leiomyomata in response to the antiprogesterone RU486. J Clin Endocrinol Metab 1993; 76:513-7.
  15. Kettel LM, Berga SL, Roseff SJ, Mortola, JF, Yen SSC. Hypothalamic-pituitary-ovarian response to clomiphene citrate in women with polycystic ovary syndrome. Fertil Steril 1993;59:532-8.
  16. Kettel LM, Murphy AA, Morales AJ, Rivier J, Vale W, Yen SSC. Rapid regression of uterine leiomyoma in response to daily administration of GnRH antagonist. Fertil Steril 1993;60:642-7.
  17. Ciaraldi T, Kettel LM, El-Roiey A, Madar Z, Reichart D, Yen SSC, Olefski J. Cellular insulin resistance in human pregnancy. Am J Obstet Gynecol 1994;170: 635-41.
  18. Murphy AA, Kettel LM, Morales AJ, Roberts V, Parmley T, Yen SSC. Endometrial effects of long-term, low dose administration of RU486. Fertil Steril 1995:63:761-6.
  19. Kettel LM, Murphy AA, Morales AJ, Yen SSC. Clinical efficacy of the antiprogesterone RU486 in the treatment of endometriosis and uterine fibroids. Hum Reprod 1994;9S:116-120.
  20. Butzow TL, Kettel LM, Yen SSC. Clomiphene citrate reduces serum insulin-like growth factor-I (IGF-I) and increases sex-hormone-binding globulin (SHBG) levels in women with polycystic ovary syndrome. Fertil Steril 1995; 63:1200-3.
  21. Haney AF, Hesla J, Hurst BS, Kettel LM, Murphy AA, Rock JA, Rowe G, Schlaff WD. Expanded polytetrafluoroethylene (Gore-Tex Surgical Membrane) is superior to oxidized regenerated cellulose (Interceed TC7) in preventing adhesions. Fertil Steril 1995; 63:1021-6.
  22. The Myomectomy Adhesion Multicenter Study Group. An expanded polytetrafluoroethylene barrier (Gore-Tex Surgical Membrane) reduces post-myomectomy adhesion formation. Fertil Steril 1995;63:491-493.
  23. Stovall TG, Muneyyirci-Delale O, Summitt RL, Scialli AR, The Leuprolide Acetate Study Group. GnRH agonist and iron versus placebo and iron in the anemic patient before surgery for leiomyomas: a randomized controlled trial. Obstet Gynecol 1995; 86:65-71.
  24. O'Shea DL, Kettel LM, Isaacs JD, Olive DL, Radwanska E, Odem RR. Ovulation induction in the poor responder or hyperresponder. Am J Obstet Gynecol 1995;172:788-91.
  25. Murphy AA, Morales AJ, Kettel LM, Yen SSC. Regression of uterine leiomyomata to the antiprogesterone RU486: dose-response effect. Fertil Steril 1995;64:187-90.
  26. Frederick JL, Ord T, Kettel LM, Stone SC, Balmaceda JP, Asch RH. Successful pregnancy outcome after cryopreservation of all fresh embryos with subsequent transfer into an unstimulated cycle. Fertil Steril 1995; 64:987-90.
  27. Kettel LM, Murphy AA, Morales AJ, Ulmann A, Baulieu E-E, Yen SSC. Treatment of endometriosis with the antiprogesterone mifepristone (RU486). Fertil Steril 1996; 65:23-28.
  28. Kettel LM, DePaulo LV, Morales AJ, Apter D, Ling N, Yen SSC. Circulating levels of follistatin throughout the reproductive life cycle in women. Fertil Steril 1996; 65:472-476.
  29. Morales AJ, Kettel LM. Quality of life assessment. Semin Reprod Endocrinol 1996; 14:155-60
  30. Dominguez CE, Kettel LM, Laughlin GA, Yen SSC. Hypoandrogenemia in patients with premature ovarian failure. (In preparation)
  31. Diamond MP, Seprafilm Adhesion Study Group. Reduction of adhesions after uterine myomectomy be Seprafilm (Hal-F): A blinded, prospective, randomized multicenter clinical study. Fertil Steril 1996; 66:904-10.
  32. Kettel LM, Hummel WP. Ovulation induction in the estrogenized anovulatory patient. Semin Reprod Endocrinol 1996; 14:309-15
  33. Kettel LM, Hummel WP. Modern medical management of endometriosis. Obstet Gynecol Clinics of North Amer 1997; 24:361-73.
  34. Hummel WP, Kettel LM. Assisted Reproductive Technology: The State of the ART. Ann Med 1997; 29:207-14.
  35. Kettel LM. San Diego County Medical Society Council Report. San Diego Physician. 1997; 37:34-6.
  36. Kettel LM, Murphy AA, Morales AJ, Yen SSC. Preliminary report of the treatment of endometriosis with low-dose mifepristone (RU486). Am J Obstet Gynecol 1998; 178:1151-6.
  37. Shekelle PG, Kahan JP, Bernstein SJ, Leape LL, Kamberg CJ, Park RE. The reproducibility of a method to identify the overuse and underuse of medical procedures. N Engl J Med 1998; 338:1888-95. Multidiciplinary panel- Kettel LM
  38. Johns DB, INTERGEL International Adhesion Study Group (Kettel LM). Clinical evaluation of INTERGEL adhesion prevention solution for the reduction of adhesions following peritoneal cavity surgery. Fertil Steril 1999, 72: Suppl S57-60.
  39. Kettel LM. Prolog: Reproductive Endocrinology and Infertility, 4th Edition. The American College of Obstetricians and Gynecologists. Washington D.C., 2000
  40. Diamond MP, Beiber E, Sepracoat and Seprafilm Study Groups (Kettel LM). Serum electrolytes, chemistries and blood cell counts after gynecologic surgery in healthy women. J Gynecol Tech (in press).
  41. diZerega GS, Verco SJS, Young P, Kettel LM, Kobak W, Martin D, Sanfilippo J, Peers EM, Scrimgeour A, Brown CB. A pilot study of the safety and efficacy of 4% icodextrin (Adept) in the reduction of adhesions following laparoscopic gynaecological surgery. Hum Reprod 2002, 17:1031-8
  42. Johns DB, Keyport GM, Hoehler F, DiZerega GS and the Intergel Adhesion Prevention Study Group (Kettel LM). Reduction of postsurgical adhesions with Intergel adhesion prevention solution: a multicenter study of safety and efficacy after conservative gynecologic surgery. Fertil Steril 2001, 76:595-604.
  43. Kettel LM. Living Life with Multiples: The Story of Jim and Jon. Infocus. Quarterly newsletter of the American Infertility Association. Spring 2003, pp22-24
  44. Garcia JE, Kettel LM, Klein NA. An aqueous formulation of recombinant human FSH is more efficient than a freeze-dried cake formulation in clomiphene-resistant women with chronic anovulation. Today’s Therapeutic Trends, 2004, 22:147-165.
  45. Kettel LM, Scholl G, Bonaventura L, Pang S, Sacks P, Chantilis S and The Follistim Pen OI Study Group. Evaluation of a pen device for self-administration of recombinant human follicle-stimulating hormone in clomiphene citrate-resistant anovulatory women undergoing ovulation induction. Reprod BioMed Online. 2004, 9:373-380 (www.rbmonline.com)
  46. Kettel LM. Looking back, looking forward in the practice of Reproductive Medicine. SREI Feedback. Summer 2004, 9:6
  47. Kettel LM. Animal product free ART: It’s been a long road. Inciid Insights Newsletter, February 2006
  48. Brown CB, Luciano AA, Martin D, Peers E, Scrimgeour A, diZerega GS and the Adept Adhesion Reduction Study Group (Kettel LM). Adept (icodextrin 4% solution) reduces adhesions after laparoscopic surgery for adhesiolysis: a double-blind, randomized, controlled study. Fertil Steril 2007, 88(5): 1413-26.
  49. Baker VL, Fujimoto VY, Kettel LM, Adamson GD, Hoehler F, Jones CE and Soules MR. Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for In-Vitro Fertilization: a randomized, multi-center, investigator-blind trial. Fertil Steril 2009, 91 (4): 1005-11.50)
  50. Pang SC and Kettel LM. Clinical experience with integrating the Follistim Pen for the self-administration of Follitropin Beta into ovarian stimulation treatment regimens. 10 Years of Follistim Branded Products and Beyond. Reproductive Medicine Upddate. Touch Briefings. September 2007, pg 20-3.
    B. Book Chapters
  51. Kettel LM, Erickson GF. Basic and Clinical Concepts in Ovulation Induction. In Advances in Obstetrics and Gynecology, Volume 1. Editor: John A. Rock. Mosby-Year Book, Inc. St. Louis, MO. 1994.
  52. Kettel LM, Murphy AA. Diagnostic and Therapeutic Laparoscopy. In Reproductive Medicine and Surgery. Editors: Edward E. Wallach and Howard A. Zacur. Mosby-Year Book Inc. St. Louis, MO, pp 509-525, 1995.
  53. Kettel LM. Abnormal Uterine Bleeding. In Current Practice of Medicine. Editor: Roger C. Bone, Section Editor: Stanley G. Korenman. Churchill Livingstone and Current Medicine, Inc. Philadelphia, PA, pp. IV:9.0-9.6, 1996.
  54. Kettel LM. Clinical Applications of RU486. Clin Obstet Gynecol, Vol 38. Editors: Roy M. Pitkin and James R. Scott. Lippincott-Raven Publishers, Philadelphia, PA. 1995; pp 921-934.
  55. Morales AJ, Kettel LM, Murphy AA. Mifepristone: Clinical Applications in General Gynecology. Clin Obstet Gynecol, Vol 39. Editors: Roy M. Pitkin and James R. Scott. Lippincott-Raven Publishers, Philadelphia, PA. 1996; pp 451-460.
  56. Kettel LM, Hummel WP. Abnormal Uterine Bleeding. In Current Practice of Medicine. Editor: Roger C. Bone, Section Editor: Stanley G. Korenman. Churchill Livingstone and Current Medicine, Inc. Philadelphia, PA, 1997.
  57. Kettel LM. Treatment of endometriosis with RU486. In Endometriosis Today: Proceedings of the Vth World Congress on Endometriosis, Yokohama, Japan. Parthenon Publishing, Lancaster, United Kingdom.
  58. Kettel LM, Murphy AA, Morales AJ, Yen SSC. Preliminary report of the treatment of endometriosis with low-dose mifepristone (RU486). In Transactions of the Pacific Coast Obstetrical and Gynecological Society. Editors: Robert Israel and Enrique C.M. de Castro, Mosby, Inc. St. Louis, MO, 1998
  59. Kettel LM, Hummel WP. Abnormal Uterine Bleeding. In Current Practice of Medicine. Editor: Roger C. Bone, Section Editor: Stanley G. Korenman. Churchill Livingstone and Current Medicine, Inc. Philadelphia, PA, 2000.
    Abstracts
  60. KKettel LM, Branch DW, Scott JR. Occult placental abruption after maternal trauma. American College of Obstetricians and Gynecologists. Las Vegas, Nevada. April 1987
  61. Hebertson RM, Kettel LM, Bryson M. Sacrospinous suspension of the prolapsed vaginal vault. Society of Gynecologic Surgery, New Orleans, Louisiana, April 1987.
  62. Kettel LM, Roseff SJ, Mortola JM, Yen SSC. Elucidation of the mechanism(s) of action of clomiphene citrate in women with polycystic ovary syndrome. Society of Gynecologic Investigation, San Diego, California, March 1989.
  63. Roseff SJ, Kettel LM, Mortola JM, Yen SSC. Hormonal dynamics following mid-luteal administration of a potent GnRH antagonist. Society of Gynecologic Investigation, San Diego, California, March 1989.
  64. Roseff SJ, Bangah ML, Kettel LM, Vale W, Rivier J, Burger HG, Yen SSC. Dynamic changes in circulating inhibin levels during the luteal-follicular transition of the human menstrual cycle. Endocrine Society, Seattle, Washington, June 1989.
  65. Roseff SJ, Kettel LM, Bangah ML, Rivier J, Burger HG, Yen SSC. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of GnRH and progesterone to late luteal phase women. Society of Gynecologic Investigation, St. Louis, Missouri, March 1990.
  66. Kettel LM, Roseff SJ, Bangah ML, Rivier J, Burger HG, Yen SSC. Hormonal dynamics following GnRH antagonist imposed follicular-follicular transition. Society of Gynecologic Investigation, St. Louis, Missouri, March 1990.
  67. Kettel LM, Roseff SJ, Bangah ML, Burger HG, Yen SSC. Circulating levels of inhibin in pregnant women at term: simultaneous disappearance with estradiol and progesterone after delivery. Society of Gynecologic Investigation, St. Louis, Missouri, March, 1990.
  68. Kettel LM, Murphy AA, Mortola JM, Dubois C, Baulieu EE, Yen SSC. Treatment of pelvic endometriosis with the antiprogesterone RU486: a pilot study. The American Fertility Society, San Francisco, CA, October 1990.
  69. Nager CW, Wujek A, Kettel LM, Chin HG, Murphy AA. Operative laparoscopy (OL) vs. laparotomy (EL) for the management of ectopic pregnancy: a randomized prospective trial. The American Fertility Society, San Francisco, CA, October 1990.
  70. Kettel LM, Morales A, Roseff SJ, Rivier J, Yen SSC. Delineation of neuroendocrine mechanism(s) in the hypersecretion of LH in polycystic ovary syndrome (PCO). Society of Gynecologic Investigation, San Antonio, TX, March, 1991.
  71. Su BC, Chan PJ, Tredway DR, Kettel M, Reindollar R, Yen SSC. Genomic analysis of insulin receptor gene in a patient with polycystic ovary syndrome, insulin resistance and acanthosis nigricans. Society of Gynecologic Investigation, San Antonio, TX, March, 1991.
  72. Murphy AA, Kettel LM, Garzo VG, Parthasarathy S. A potential role for oxidized LDL in endometriosis related infertility. Society for Gynecologic Investigation, San Antonio, TX, March 1991.
  73. Kettel LM, Morales A, Yen SSC. Response of uterine fibroids to the antiprogesterone RU486: A pilot study. The American Fertility Society, Orlando, FL, October 1991.
  74. Murphy AA, Garzo VG, Morales A, Kettel LM, Parthasarathy S. Effects of oxidized LDL on human sperm motility: A possible role in endometriosis associated infertility. The American Fertility Society, Orlando, FL, October 1991.
  75. Kettel LM, DePaolo L, Ling N, Yen SSC. Follistatin: Circulating levels during the menstrual cycle and response to gonadal suppression. Society for Gynecologic Investigation, San Antonio, TX, March 1992.
  76. Kettel LM, Greene K, Yen SSC. Endometrial dyssynchronization without hormonal changes by the antiprogesterone RU486 during the luteal phase of the menstrual cycle: A contraceptive potential. Society for Gynecologic Investigation, San Antonio, TX, March 1992.
  77. Murphy AA, Morales AJ, Sinich CM, Kettel LM. Morphologic and steroid receptor response of myometrium and leiomyomata to long term administration of RU486. Society for Gynecologic Investigation, San Antonio, TX, March 1992.
  78. Kettel LM, Roseff SJ, Murphy AA, Yen SSC. Hormonal changes during failed clomiphene citrate (CC) cycles in women with polycystic ovary syndrome (PCO). Pacific Coast Fertility Society, La Mirada, CA, April 1992.
  79. Butzow T, Kettel LM. Circulating gonadotropin levels in polycystic ovary syndrome (PCO), Kallmann's syndrome and normal cycling women: Comparison of highly sensitive immunoflurometric assay and conventional RIA. The Endocrine Society, San Antonio, TX, June 1992.
  80. Ciaraldi T, Kettel LM, El-Roiey A, Madar Z, Reichart D, Yen SSC, Olefski J. Cellular insulin resistance in human pregnancy. Ninth International Congress of Endocrinology, Nice, France 1992.
  81. Murphy AA, Kettel LM, Morales AJ, Yen SSC. Progesterone antagonists in the treatment of endometriosis and leiomyomata uteri. Terra Symposium, Mohonk, NY. May 1992.
  82. Kettel LM, Murphy AA, Rivier J, Vale W, Yen SSC. Clinical and endocrine effects of long-term NAL-GLU GnRH antagonist in normal cycling women with uterine fibroids. The American Fertility Society, New Orleans, LA, November 1992.
  83. Kettel LM, Morales A, Apter D, Ling N, DePaulo L, Yen SSC. Circulating levels of follistatin throughout the reproductive life-cycle of women. The American Fertility Society, New Orleans, LA, November 1992.
  84. Morales AJ, Butzow T, Laughlin GA, Kettel LM, Nelson JC, Yen SSC. Alterations of insulin-IGF-IGFBP axis in women with functional hypothalamic amenorrhea (FHA). The American Fertility Society, New Orleans, LA, November 1992.
  85. Schlaff WD, Hurst BS, Kettel LM, Murphy AA, Franklin, R, Lotze G, Rowe A, Haney A, March C, Tjaden B, Helsa J, Rock JA, Boyers S, Luciano A, Metzger D, Holtz, G, Patton G. Prevention of pelvic sidewall adhesions using barrier methods: e-PTFE (Gore-Tex Surgical Membrane) and oxidized regenerated cellulose (Interceed, TC7): Preliminary Report. The American Fertility Society, New Orleans, LA. November 1992.
  86. Murphy AA, Morales AJ, Kettel LM, Yen SSC. Endometrial effects of long term, low dose administration of RU486 in cycling women. Society for Gynecologic Investigation, Toronto, ON, Canada, March 1993.
  87. Murphy AA, Kettel LM, Morales AJ, Yen SSC. Regression of uterine leiomyomata to the antiprogesterone RU486: dose response effect. Society for Gynecologic Investigation, Toronto, ON, Canada, March 1993.
  88. Kettel LM, Murphy AA, Holden JP, Ulman A, Yen SSC. Long-term, low-dose RU486 in the treatment of endometriosis. Society for Gynecologic Investigation, Toronto, ON, Canada, March 1993.
  89. Kettel LM. Follicular arrest during the midfollicular phase of the menstrual cycle: a gonadotropin-releasing hormone antagonist imposed follicular-follicular transition. OB/GYN Digest 1992;6:24-25.
  90. Butzow TL, Kettel LM, Yen SSC. Clomiphene citrate reduces circulating levels of IGF-I in polycystic ovary syndrome. The Endocrine Society, Las Vegas, NV, June 1993.
  91. Dominguez C, Liu CH, Kettel LM. Androgen levels in premature ovarian failure. The Endocrine Society, Las Vegas, NV, June 1993.
  92. Huang PL, Murphy AA, Kettel LM. Pelvic adhesions at time of second-look laparoscopy after myomectomy. Pacific Coast Fertility Society, Indian Wells, CA, April 1994.
  93. Huang PL, Kettel LM, Yen SSC. Effects of antiestrogen on the growth hormone-insulin-like growth factor system in normal cycling women. The Endocrine Society, Anaheim, CA. June 1994.
  94. Huang PL, Kettel LM, Yen SSC. Effect of the antiestrogen clomiphene citrate on the growth hormone-insulin-like growth factor system in women with polycystic ovarian syndrome. The American Fertility Society. San Antonio, TX. November 1994.
  95. Haney AF, Hesla J, Hurst BS, Kettel LM, Murphy AA, Rock JA, Rowe G, Schlaff WD. Prevention of pelvic sidewall adhesion reformation using surgical barriers: expanded-polytetrafluoroethylene (Gore-Tex Surgical Membrane) is superior to oxidized regenerated cellulose (Interceed TC72). The American Fertility Society. San Antonio, TX. November 1994.
  96. Tulandi T, Rowe G, Rock J, Murphy AA, Lotze E, Kettel LM, Haney A, Franklin R. Effects of expanded polytetrafluoroethylene, GORE-TEX surgical membrane on postmyomectomy adhesion. The American Fertility Society. San Antonio, TX, November 1994.
  97. Kettel LM. The clinical efficacy of the antiprogesterone RU486 in the treatment of endometriosis and uterine fibroids. National Institutes of Health, National Institute of Child Health and Human Development, Bethesda, MD. May 1994.
  98. Goldsman MP, Balmaceda JP, Stone SC, Frederick JL, Kettel M, Asch RH. Use of albumin in the prevention of OHSS. Pacific Coast Fertility Society, Coronado, CA, April 1995.
  99. Kettel LM. Treatment of endometriosis with RU486. Vth World Congress on Endometriosis. Yokohama, Japan. October 24, 1996
  100. Kettel LM, Murphy AA, Morales AJ, Yen SSC. The Efficacy of RU486 in the Treatment of Endometriosis: a Dose Response Study. Pacific Coast Obstetrical and Gynecological Society. Coeur D’Alene, ID, September 1997.
  101. Kettel LM, Venier WC, Hummel WP, Chan SYW. Blastocyst transfer significantly improves pregnancy success in an egg donation program. Pacific Coast Reproductive Society. La Costa, CA, April 16, 1999.
  102. Chan SYW, Venier WC, Hummel WP, Kettel LM. Extended culture of frozen-thawed, early stage embryos to day 6 improves the clinical pregnancy rate with the replacement of a limited number of embryos. Pacific Coast Reproductive Society. La Costa, CA, April 16, 1999.
  103. Diamond M, Luciano A, Young P, Kettel LM, Johns DA, Kim AH. A randomized, controlled, single blind trial to evaluate the safety, plasma time course, and efficacy of Flogel for the reduction of post-surgical adhesions. Fourth International Conference on Postoperative Healing and Adhesions, Fort Lauderdale, FA, October 1999.
  104. Kettel LM, INTERGEL International Adhesion Study Group. Reduction of adhesions with Intergel adhesion prevention solution following conservative surgery. Global Congress of Gynecologic Endoscopy. Las Vegas, NV, November 10, 1999.
  105. Chan S, Venier W, Andersen P, Christiansen C, Londerholm S, Tobias T, O’Kane C, Hummel W, Kettel LM. Blastocyst culture: analysis of factors affecting the development of embryos to the blastocyst stage. Pacific Coast Reproductive Society, Rancho Mirage, CA, April 30, 2000.
  106. Chan S, Venier W, Andersen P, Christiansen C, Londerholm S, Tobias T, O’Kane C, Hummel W, Kettel LM. ICSI and blastocyst transfer: Patient age and oocytes/embryo factors, but not general sperm parameters are related to pregnancy outcome. Pacific Coast Reproductive Society, Rancho Mirage, CA, April 30, 2000.
  107. Kettel LM, Ota M, Buyalos RP, Hummel WP. A comparison of Day 3 FSH and estradiol levels using two assay systems. Pacific Coast Reproductive Society, Rancho Mirage, CA, April 30, 2000.
  108. Werlin LB, DeCherney A, Rodi I, Hill D, Marello E, Munne S and the Genesis Network for Reproductive Health (Kettel LM). Preimplantation genetic diagnosis (PGD) as both a diagnostic and therapeutic tool in assisted reproductive technology (ART). American Society for Reproductive Medicine, Seattle, WA, October 2002
  109. Branigan EF, Estes MA. A randomized clinical trial of treatment of clomiphene citrate (CC) resistant anovulation using oral contraceptive pill (OC) suppression and repeat CC treatment. Foraml Discussant: L. M. Kettel. Pacific Coast Obstetrical and Gynecological Society. Rancho Mirage, CA, October 2002.
  110. Kettel LM, Scholl G, Bonaventura L, Pang S, Sacks S, Chantilis S. (The Follistim PenÔ OI Study Group). Evaluation of Follistim Pen injector for self-administration of Follistim® AQ (in cartridge) in women undergoing ovulation induction. Pacific Coast Reproductive Society. Rancho Mirage, CA April 24, 2003.
  111. Letterie G. The use of three-dimensional ultrasound to detect the placement of the embryo transfer catheter Formal Discussant: L. M. Kettel. Pacific Coast Obstetrical and Gynecological Society. Phoenix, AZ. September 2004.
  112. Marin De Ugarte C, Li M, DeCherney A, Danzer H, Surrey M, Hill D. Accuracy of FISH in predicting chromosomal status in PGD. Formal Discussant: L. M. Kettel. Pacific Coast Reproductive Society, Indian Wells, CA May 2005.
  113. Werlin LB, DeCherney A, Rodi I, Kettel LM, Shapiro B, Munne S and the Genesis
    Network for Reproductive Health. Preimplantation genetic diagnosis (PGD) as a beneficial tool in women with recurrent pregnancy loss (RPL) and advanced maternal age (AMA). American Society for Reproductive Medicine, Montreal, Canada, October 2005 (submitted).
  114. Werlin LB, DeCherney A, Rodi I, Kettel LM, Shapiro B, Johnson M and the Genesis
    Network for Reproductive Health. Preimplantation genetic diagnosis (PGD) as a tool to lower multi-fetal pregnancy rates. American Society for Reproductive Medicine, New Orleans, October 2006.
  115. Mi CW, Venier WC, Kokjohn SN, Hummel WP, Kettel LM . Comparison of two human embryo transfer media in blastocyst frozen embryo transfer cycles. American Society for Reproductive Medicine, Washington DC, October 2007.